Clinical phenotyping uncovers heterogeneous associations between corticosteroid treatment and survival in critically ill COVID-19 patients.

MLA

Bruse, Niklas, et al. “Clinical Phenotyping Uncovers Heterogeneous Associations between Corticosteroid Treatment and Survival in Critically Ill COVID-19 Patients.” Intensive Care Medicine, vol. 50, no. 11, Nov. 2024, pp. 1884–96. EBSCOhost, https://doi.org/10.1007/s00134-024-07593-3.

APA

Bruse, N., Motos, A., van Amstel, R., de Bie, E., Kooistra, E. J., Jansen, A., van Lier, D., Kennedy, J., Schwarzkopf, D., Thomas-Rüddel, D., Bermejo-Martin, J. F., Barbe, F., de Keizer, N. F., Bauer, M., van der Hoeven, J. G., Torres, A., Seymour, C., van Vught, L., Pickkers, P., & Kox, M. (2024). Clinical phenotyping uncovers heterogeneous associations between corticosteroid treatment and survival in critically ill COVID-19 patients. Intensive Care Medicine, 50(11), 1884–1896. https://doi.org/10.1007/s00134-024-07593-3

Chicago

Bruse, Niklas, Anna Motos, Rombout van Amstel, Eckart de Bie, Emma J. Kooistra, Aron Jansen, Dirk van Lier, et al. 2024. “Clinical Phenotyping Uncovers Heterogeneous Associations between Corticosteroid Treatment and Survival in Critically Ill COVID-19 Patients.” Intensive Care Medicine 50 (11): 1884–96. doi:10.1007/s00134-024-07593-3.